Pulse Biosciences (PLSE) Deferred Taxes (2015)

Pulse Biosciences (PLSE) recorded quarterly Deferred Taxes of -$518000.0 in Q4 2015, down 7.25% quarter-over-quarter from -$483000.0 in Q3 2015.

Pulse Biosciences (PLSE) Deferred Taxes (2015) Analysis & Trends

Pulse Biosciences' Deferred Taxes history runs 1 years deep, the most recent figure standing at -$518000.0 for Q4 2015.

In Q4 2015, Deferred Taxes changed N/A year-over-year to -$518000.0; the TTM figure through Dec 2015 stood at -$1.7 million (changed N/A YoY), while the FY2015 annual figure was -$1.7 million, down 7104.35% from the prior year.
Deferred Taxes was -$518000.0 for Q4 2015 at Pulse Biosciences, down from -$483000.0 in the prior quarter.
In the past five years, Deferred Taxes ranged from a high of -$299000.0 in Q1 2015 to a low of -$518000.0 in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	-339.30 Mn
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	-73.00 Mn
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	37.00 Mn
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	-
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	-
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	-41.00 Mn
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	43.50 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	40.64 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	29.00 Mn
10	Pulse Biosciences	1.68 Bn	1.68 Bn	-	-

Download Data